Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Profit After Tax: 2017-2025

Historic Profit After Tax for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $21.6 million.

  • Organogenesis Holdings' Profit After Tax rose 74.90% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 113.62%. This contributed to the annual value of $861,000 for FY2024, which is 82.59% down from last year.
  • As of Q3 2025, Organogenesis Holdings' Profit After Tax stood at $21.6 million, which was up 329.63% from -$9.4 million recorded in Q2 2025.
  • Organogenesis Holdings' Profit After Tax's 5-year high stood at $51.0 million during Q4 2021, with a 5-year trough of -$18.8 million in Q1 2025.
  • For the 3-year period, Organogenesis Holdings' Profit After Tax averaged around -$78,273, with its median value being -$568,000 (2023).
  • As far as peak fluctuations go, Organogenesis Holdings' Profit After Tax soared by 1,450.88% in 2024, and later slumped by 797.29% in 2025.
  • Organogenesis Holdings' Profit After Tax (Quarterly) stood at $51.0 million in 2021, then plummeted by 85.32% to $7.5 million in 2022, then slumped by 107.59% to -$568,000 in 2023, then surged by 1,450.88% to $7.7 million in 2024, then skyrocketed by 74.90% to $21.6 million in 2025.
  • Its Profit After Tax was $21.6 million in Q3 2025, compared to -$9.4 million in Q2 2025 and -$18.8 million in Q1 2025.